Simufilam dihydrochloride is an orally bioavailable small molecule that selectively binds to misfolded filamin A (FLNA) in Alzheimers disease research. It restores FLNAs normal function, which has been shown in experimental models to improve synaptic signaling and reduce neuroinflammation by disrupting pathological protein interactions.